Production (Stage)
Precigen, Inc.
PGEN
$1.33
$0.000.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 24.69% | -3.76% | -30.91% | -60.05% | -42.90% |
| Total Other Revenue | 187.50% | 266.67% | 0.00% | 160.00% | -- |
| Total Revenue | 25.92% | -3.09% | -30.89% | -59.42% | -42.46% |
| Cost of Revenue | 2.33% | 8.54% | -34.35% | 23.11% | -92.15% |
| Gross Profit | 2,510.00% | -8.83% | 64.56% | -35.46% | 99.92% |
| SG&A Expenses | 21.75% | 7.16% | 6.96% | 10.63% | -12.78% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.04% | -2.80% | -0.45% | 18.03% | 0.58% |
| Operating Income | 7.43% | 2.79% | -1.55% | -24.51% | -3.97% |
| Income Before Tax | -127.85% | 40.66% | -21.03% | -196.71% | -4.29% |
| Income Tax Expenses | -- | 73.80% | 300.00% | -2,498.46% | 47.27% |
| Earnings from Continuing Operations | -128.13% | 40.32% | -21.13% | -189.34% | -4.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -128.13% | 40.32% | -21.13% | -189.34% | -4.42% |
| EBIT | 7.43% | 2.79% | -1.55% | -24.51% | -3.97% |
| EBITDA | 3.72% | -1.38% | -6.75% | -27.14% | -4.81% |
| EPS Basic | -93.59% | 49.32% | -9.03% | -184.49% | 3.74% |
| Normalized Basic EPS | -93.29% | 15.19% | -9.04% | -24.90% | 3.87% |
| EPS Diluted | -93.59% | 49.32% | -9.03% | -184.49% | 3.74% |
| Normalized Diluted EPS | -93.29% | 15.19% | -9.04% | -24.90% | 3.87% |
| Average Basic Shares Outstanding | 17.92% | 17.77% | 11.01% | 1.76% | 8.46% |
| Average Diluted Shares Outstanding | 17.92% | 17.77% | 11.01% | 1.76% | 8.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |